I'm not sure exactly what you mean, and I don't know for sure the numbers. So please take these as indicative, not absolute.
But as I understand it, what we know is:
A large number of people have been dosed, divided 50:50 active to placebo. Let's say 10,000 each for arguments sake. The 10,000 on placebo have no protection.
100 people of 10,000 on the placebo arm got symptomatic covid.
30 people of 10,000 on the active arm got symptomatic covid.
Of the 30 cases on the active arm, they announced none were "severe". I don't think we know how many for the placebo - I don't recall seeing it.
They were also testing everyone weekly. We don't know how many people on either arm tested positive without symptoms.
I think you're asking if the vaccine protects against serious disease ie you get a milder case if you get it? The implication of the above is "probably", but it may be that there aren't sufficient severe cases on the placebo arm to draw a strong conclusion that the lack of severe cases on the active arm means much.
The big picture remains: even the worst case efficacy for seems good enough to reduce covid to not much worse than flu, and therefore lift restrictions.